CONTROL OF AN SIVMAC239 TRANSMEMBRANE MUTANT IN PIGTAIL MACAQUES
CONTROL OF AN SIVMAC239 TRANSMEMBRANE MUTANT IN PIGTAIL MACAQUES
批准号:
8358143
负责人:
James A Hoxie
金额:
$5.78万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-01 至 2012-04-30
关键词:
Acquired Immunodeficiency SyndromeAcuteBromodeoxyuridineCD4 Positive T LymphocytesCytoplasmic TailDiseaseExhibitsFundingGrantImmune responseInfectionLabelLamina PropriaMacaca mulattaMacaca nemestrinaMutationNational Center for Research ResourcesPrimatesPrincipal InvestigatorRNARecoveryResearchResearch InfrastructureResourcesSIVSignal TransductionSourceUnited States National Institutes of HealthViralViruscostdisorder controlinterestmacrophagemicrobialmonocytemutanttrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
The pigtail macaque (PTM) is well recognized as being highly susceptible to SIV-induced disease, with SIVmac239 reproducibly and rapidly causing AIDS. We have shown that when SIVmac239 contains a mutation that ablates a GYxx¿ trafficking signal in the Env TM cytoplasmic tail, the resulting virus (GY) replicates to a high acute RNA peak (1.8-9.3x10^6 copies/ml) comparable to SIVmac239 in PTMs (p=0.90) and to GY in rhesus macaques (RhM) (p=0.93). In RhMs (n=4) GY acute infection is followed by a 2-3 log reduction in viral set point (VSP) with minimal acute loss of CD4 cells in the lamina propria, but with a gradual decline in CD4 cells over 1 year. However, in PTMs (n=4) with the onset of host immune responses GY is suppressed to extremely low to undetectable levels (15, 15, 15, and 210 copies/ml by 19 weeks post infection), much lower than SIVmac239 (p=0.003) and GY (p=0.007) in RhM. Strikingly, the sustained, severe depletion of lamina propria CD4 T-cells that occurs with SIVmac239 infection did not occur with GY in PTM; from preinfection levels (median 43.9 %; range 25.4 54.3%) only a modest reduction occurred during acute infection (median 18.4 %; range 8.4 20.7%) with evidence of recovery by 22 weeks (median 27 %; range 18.3 - 46%). Moreover, monocyte turnover, determined by BrdU labeling, which we have shown increases with pathogenic SIV infection, was only minimally and transiently increased in GY-infected PTMs compared to SIVmac239-infected RhMs (p=0.03), possibly reflecting a lower level of microbial translocation and/or macrophage infection. GY control is clearly not the result of poor replicative ability, given its high acute viral peak in both PTM and RhM. How the GY mutation alters the pathogenic potential of SIVmac239 and why PTMs, a more susceptible species for pathogenic SIVmac infection, exhibit better control of ¿GY than RhM will be of great interest in determining viral and host interactions that are relevant to virologic control and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted interventions to reduce or eliminate the SIV reservoir in a novel model of elite control
-
批准号:10013657
-
项目类别:
-
资助金额:$85.02万
-
财政年份:2020
-
负责人:James A Hoxie
-
依托单位:
Targeted interventions to reduce or eliminate the SIV reservoir in a novel model of elite control
-
批准号:10371090
-
项目类别:
-
资助金额:$78.77万
-
财政年份:2020
-
负责人:James A Hoxie
-
依托单位:
Role of SIV and HIV Env cytoplasmic tail in pathogenesis and protective immunity
-
批准号:10092084
-
项目类别:
-
资助金额:$76.19万
-
财政年份:2018
-
负责人:James A Hoxie
-
依托单位:
Non-CD4 tropic SIV: Enhancing CD4 T-cell help in antiviral immune responses
-
批准号:8732145
-
项目类别:
-
资助金额:$84.23万
-
财政年份:2014
-
负责人:James A Hoxie
-
依托单位:
PATHOGENESIS OF AN ATTENUATED SIVMAC239 IN RHESUS AND PIGTAIL MACAQUES
-
批准号:8358095
-
项目类别:
-
资助金额:$5.78万
-
财政年份:2011
-
负责人:James A Hoxie
-
依托单位:
Optimizing HIV Env immuogens for T and B cell vaccine responses
-
批准号:8505364
-
项目类别:
-
资助金额:$51.77万
-
财政年份:2010
-
负责人:James A Hoxie
-
依托单位:
Optimizing HIV Env immuogens for T and B cell vaccine responses
-
批准号:8091276
-
项目类别:
-
资助金额:$65.41万
-
财政年份:2010
-
负责人:James A Hoxie
-
依托单位:
Optimizing HIV Env immuogens for T and B cell vaccine responses
-
批准号:7988637
-
项目类别:
-
资助金额:$58.7万
-
财政年份:2010
-
负责人:James A Hoxie
-
依托单位:
Optimizing HIV Env immuogens for T and B cell vaccine responses
-
批准号:8300199
-
项目类别:
-
资助金额:$55.19万
-
财政年份:2010
-
负责人:James A Hoxie
-
依托单位:
PATHOGENIC DETERMINANTS OF THE SIV ENVELOPE TRANSMEMBRANE CYTOPLASMIC DOMAIN
-
批准号:8173001
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:James A Hoxie
-
依托单位:
PATHOGENIC DETERMINANTS OF THE SIV ENVELOPE TRANSMEMBRANE CYTOPLASMIC DOMAIN
-
批准号:7958683
-
项目类别:
-
资助金额:$6.27万
-
财政年份:2009
-
负责人:James A Hoxie
-
依托单位:
Pilot Projects
-
批准号:7981648
-
项目类别:
-
资助金额:$24.67万
-
财政年份:2009
-
负责人:James A Hoxie
-
依托单位:
Administrative
-
批准号:7684965
-
项目类别:
-
资助金额:$29.47万
-
财政年份:2009
-
负责人:James A Hoxie
-
依托单位:
PATHOGENESIS OF AN X4-TROPIC VARIANT OF SIVMAC239
-
批准号:7958703
-
项目类别:
-
资助金额:$5.81万
-
财政年份:2009
-
负责人:James A Hoxie
-
依托单位:
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain
-
批准号:8471046
-
项目类别:
-
资助金额:$95.15万
-
财政年份:2008
-
负责人:James A Hoxie
-
依托单位:
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain
-
批准号:8847629
-
项目类别:
-
资助金额:$79.52万
-
财政年份:2008
-
负责人:James A Hoxie
-
依托单位:
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain
-
批准号:7579899
-
项目类别:
-
资助金额:$94.16万
-
财政年份:2008
-
负责人:James A Hoxie
-
依托单位:
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain
-
批准号:8279208
-
项目类别:
-
资助金额:$81.37万
-
财政年份:2008
-
负责人:James A Hoxie
-
依托单位:
Administrative Core
-
批准号:7699957
-
项目类别:
-
资助金额:$25.96万
-
财政年份:2008
-
负责人:James A Hoxie
-
依托单位:
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain
-
批准号:7422256
-
项目类别:
-
资助金额:$64.37万
-
财政年份:2008
-
负责人:James A Hoxie
-
依托单位:
海外基金